Gabriel Ling

All filings by Gabriel Ling on record concern Starling Oncology, Inc. We count 6 filings; the first trade dates from 17 November 2022 and the latest from 20 November 2025.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 24 November 2025, reports a share grant in Starling Oncology, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.